News – Page 724 – Endpoints News

Dean Li invites another under-the-radar biotech to Merck's dealmaking table as Amathus signs neurodegeneration pact

5 years ago

Europe mulls halting Covid-19 vaccine exports to some countries

5 years ago

A departing CMO pens a sad farewell as he heads back to the UK biopharma scene

5 years ago

Court win for Eli Lilly halts HHS’s drug discount rule

5 years ago

Hunting unicorn status, the co-inventors of the Oxford-AstraZeneca vaccine raise a monster B round

5 years ago

After a roller coaster ride, Sage COO strikes out on his own to chart a new biotech path

5 years ago

Covid-19 roundup: Alnylam, Vir quietly deprioritize Covid-19 drug; Data suggest AstraZeneca's vaccine is only 10.4% ...

5 years ago

Another bluebird exec jumps ship as questions swirl over gene therapies and imminent split

5 years ago

Montreal AI startup with a touted advisor licenses its 'few-shot' platform to Repare for synthetic lethality ...

5 years ago

Eli Lilly, Novartis back a biotech startup boasting 'best of both worlds' protein degraders

5 years ago

Fresh out of the bluebird bio oncology split, Joanne Smith-Farrell flies the coop to Be Bio and its B cell platform

5 years ago

FTC pledges to aggressively crack down on pharma mergers

5 years ago

Roche builds long-term case for Evrysdi with 2-year SMA data; ExeVir nets $50M Series A for llama-derived Covid ...

5 years ago

Covid-19 roundup: As AstraZeneca deals with vaccine woes, US turns attention to its antibody treatment; Moderna doses ...

5 years ago

With all the buzz in gene therapy, Sanofi offloads two small molecule sickle cell programs from $11.6B buyout to ...

5 years ago

Can a CRISPR startup succeed where Pfizer, GlaxoSmithKline, Biogen and Genentech failed and cure chronic pain?

5 years ago

Merck wins priority review for rare carcinoma drug belzutifan, the centerpiece of $1B+ Peloton buyout

5 years ago

Eli Lilly's IL-23 inhibitor mirikizumab shows late-stage promise in ulcerative colitis — but AbbVie's Skyrizi looms

5 years ago

Takeda, Sarepta double down on a biotech partner's platform to engineer better AAV capsids by mapping out their ...

5 years ago

FDA requires Regeneron, Lilly to monitor variants as a condition of mAb EUAs

5 years ago

Taiwan's Acepodia closes Series B with the promise of conjugating antibodies and off-the-shelf NK cells

5 years ago

AbbVie looks to shed Allergan's legacy women's health unit as it hunkers down for Humira biosim doomsday — report

5 years ago

No quick redemption for GlaxoSmithKline’s $4B alliance with Merck KGaA as bispecific cancer drug flunks a second ...

5 years ago

Solid Bio’s long, troubled slog through the clinic yields 'encouraging' early data and no new safety concerns. It's ...

5 years ago

First page Previous page 721 722 723724725 726 727 Next page Last page